Advertisement

Related Videos

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

David A. Hyman, MD, JD, on Inclusive Shared Savings

Opening Session Panel Discussion

Advertisement

Advertisement




Apr
09
Today In Oncology
Researchers Identify Blood-Based Biomarker for Cancer Risk in People With Lynch Syndrome
Final Report on Pralsetinib in Advanced RET Fusion–Positive NSCLC
New ASH HematOmics Program Offers Blood Cancer Data Integration Tool to Accelerate Research
Ulrich Steidl, MD, PhD, Named Director of Montefiore Einstein Comprehensive Cancer Center
How Cannabis Use May Be Accelerating Breast and Testicular Cancer Rates in AYAs
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo